About BSD domain-containing protein 1
BSD domain-containing protein 1 (BSDC1) is a protein
from Homo sapiens identified by UniProt accession
Q9NW68, 430 residues long.
MolForge cross-references it against 0 known binders and
12 disease associations.
Target properties
| Protein name | BSD domain-containing protein 1 |
|---|
| UniProt accession | Q9NW68 |
|---|
| Gene | BSDC1 |
|---|
| Organism | Homo sapiens |
|---|
| Length | 430 residues |
|---|
| Molecular weight | — |
|---|
| EC numbers | — |
|---|
| Target class | UNCLASSIFIED |
|---|
| Subcellular location | — |
|---|
| Keywords | — |
|---|
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
|---|
| Druggability score | — |
|---|
| Pocket score | — |
|---|
| Max clinical phase | — |
|---|
Disease associations (12)
Diseases linked to this target (Open Targets).
- total blood protein measurement · score 0.09
- insomnia · score 0.09
- viral load · score 0.06
- myeloid sarcoma · score 0.01
- cancer · score 0.01
- idiopathic pulmonary arterial hypertension · score 0.00
- age-related macular degeneration · score 0.00
- glioblastoma · score 0.00
- neoplasm · score 0.00
- head and neck squamous cell carcinoma · score 0.00
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
|---|
| AF-Q9NW68-F1 | alphafold | PREDICTED | 61.80 | — |
Amino-acid sequence (430 residues)
MAEGEDVGWW RSWLQQSYQA VKEKSSEALE FMKRDLTEFT QVVQHDTACT IAATASVVKE KLATEGSSGA TEKMKKGLSD FLGVISDTFA PSPDKTIDCD VITLMGTPSG TAEPYDGTKA RLYSLQSDPA TYCNEPDGPP ELFDAWLSQF CLEEKKGEIS ELLVGSPSIR ALYTKMVPAA VSHSEFWHRY FYKVHQLEQE QARRDALKQR AEQSISEEPG WEEEEEELMG ISPISPKEAK VPVAKISTFP EGEPGPQSPC EENLVTSVEP PAEVTPSESS ESISLVTQIA NPATAPEARV LPKDLSQKLL EASLEEQGLA VDVGETGPSP PIHSKPLTPA GHTGGPEPRP PARVETLREE APTDLRVFEL NSDSGKSTPS NNGKKGSSTD ISEDWEKDFD LDMTEEEVQM ALSKVDASGE LEDVEWEDWE
Explore BSD domain-containing protein 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets